About HUB:

Hubrecht Organoid Technology (HUB) is a fast-growing biotech company, founded on the pioneering work of Prof. Dr. Hans Clevers who discovered methods to grow stem cell-derived human epithelial “mini-organs” (organoids) from tissues of patients with various diseases including cancer and cystic fibrosis. HUB builds comprehensive Living Biobanks of well-characterized organoids and develops assays for drug screening and validation. The Organoid Technology enables predictive diagnostics and clinical trial patient stratification.

We are currently seeking a highly motivated Biostatistician for one of our Research Groups.


Scope of position:

A Biostatistician at HUB supports Clinical Research Projects focussed on the validation of organoids as a clinically relevant system for drug development and personalized medicine. This position allows you to drive state of the art research with the aim to develop innovative diagnostic tools using Organoid Technology.

As a Biostatistician at HUB, you will be working with the top researchers in the field of adult (cancer) stem cells and 3D culture. You will interact with external parties and present novel findings at international scientific meetings.

The successful candidate will learn from and contribute to the world leader biotech company on Organoid Technology that has already disrupted human health, providing patients access to novel treatments.



Suitable candidates  have a PhD in the field of Life Science, (bio)statistics, mathematics or a related field, followed by at least one-year of postdoc experience, or equivalent experience.

Research background in one or more of the following areas is preferred:

  • Comprehensive knowledge of statistical theory and methods,
  • Advanced command of statistical packages, preferably R (and/or others such as SAS),
  • Knowledge of the basic approaches used in clinical research and epidemiology,
  • An ability to independently design and review clinical protocols and / or statistical analysis plans.


We are seeking an individual with deep intellectual curiosity, and excellent communication and interpersonal skills.


What we offer:

Genuinely meaningful work as part of a company with unwavering commitment to apply its Organoid Technology globally for the benefit of the patients.

Generous annual leave of 30,5 days plus national holidays (fulltime equivalent).

Pension Plan with 2/3 contribution paid by HUB.

A unique opportunity to be part of further development and implementation of this innovative technology.


Please send your cover letter and resume, in English to;

We look forward to hearing from you!

January 19, 2021 SLAS 2021 Educational Track: Automation Technologies This track focuses on the innovative use of biological or chemistry applicati... read more
September 04, 2020 HUB and BGI-Qingdao sign a Memorandum of Unde... Utrecht and Qingdao, Sep 4th, 2020 – Hubrecht Organoid Technology (HUB) and BGI-Qingdao announced today that they ... read more
May 27, 2020 Studying the development of ovarian cancer wi... read more